申请人:Encysive Pharmaceuticals, Inc.
公开号:US07319111B2
公开(公告)日:2008-01-15
The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.
本发明涉及尿泊肽 II 受体拮抗剂、CCR-9 拮抗剂、包含它们的制药组合物及其用途。